Advisory Board

Last year saw the introduction of the GTNF advisory board, created by Tobacco Reporter magazine. Comprising industry leaders from various tobacco business segments and chaired by British American Tobacco’s David O’Reilly, the 2015 advisory board renews its focus in supporting the evolution of the GTNF into a world-class networking and knowledge-sharing forum.

As part of its mission, the board will provide insight and timely knowledge about upcoming trends to inform the conference program and help ensure that relevant political, legislative and regulatory developments are thoroughly covered. Tobacco Reporter is pleased to present its advisory board members below.

GTNF 2015 will be held at the Palazzo Re Enzo in Bologna, Italy on 15, 16 and 17 September.


david oreilly David O’Reilly is British American Tobacco’s (BAT) group scientific and R&D director. He graduated from Imperial College London in 1991 with a Ph.D. in molecular virology. He continued to pursue this area of research when he joined Advanced Technologies Cambridge, a BAT subsidiary, where he studied the potential of genetic modification to introduce novel processing and agronomic traits into tobacco and other crops. O’Reilly has been a driving force behind BAT’s multidisciplinary global R&D effort in consumer-led, science-based innovation in both combustible and next-generation tobacco and nicotine products. He has also led the company’s programs in corporate social responsibility and scientific and public health policy and engagement. O’Reilly is the current chairman of the Global Tobacco & Nicotine Forum advisory board.
John Clayton John Clayton  is group head of government affairs at British American Tobacco (BAT), based in London, U.K. Previously, Clayton was Vice President of Corporate and Regulatory Affairs for Imperial Tobacco, Canada. From 2006 to 2008, he held the post of Programme Manager of the Global Harm Reduction Programme for BAT; prior to this he was International Regulatory and Public Affairs Manager and has also been Manager of Corporate Social Responsibility for BAT in Japan. Clayton speaks Japanese fluently.
kirsty green-mann Kirsty Green-Mann is imperial tobacco group’s head of corporate responsibility. Based in Bristol, U.K., her remit includes definition and implementation of the company’s responsibility strategy, stakeholder engagement, partnership and community investment, CR reporting and human rights. Green-Mann joined Imperial in 1998 and has held a variety of roles relating to technical support, product development, process improvement, quality management, project management, corporate affairs and company secretariat.
mark-kehaya Mark Kehaya is chairman of the board of Alliance One International (AOI), a position he has held since December 2010. He served as interim CEO of AOI from December 2010 until February 2013. From April 1993 to March 2000, he was employed by Standard Commercial Corp., a predecessor company to AOI, serving as assistant to the president, finance director of the tobacco division, vice president for planning and CEO of Standard Commercial’s tobacco processing facility in St. Petersburg, Russia. Kehaya remains a founding partner at Meriturn Partners LLC, an investment firm specializing in restructurings and turnarounds of middle-market companies.
chris koddermann Chris Koddermann is director of government affairs at Philip Morris International (PMI). Based at PMI’s operations center in Switzerland, Koddermann provides PMI regions and markets with strategic advice and support in the design and execution of regulatory and reduced-risk product campaigns. Prior to moving to Switzerland, Koddermann headed up the corporate affairs function for PMI’s Canadian affiliate, Rothmans, Benson & Hedges. Koddermann has worked as a public policy specialist and senior adviser to ministers in Canada’s federal and provincial governments. In addition, Koddermann has managed or been a senior adviser on a number of provincial and federal election campaigns.
Patricia Kovacevic 1 - Copy Patricia I. Kovacevic, Esq. is the general counsel and chief compliance officer of Nicopure Labs LLC, the leading e-liquid and vaping device manufacturer of U.S.- made Halo and eVo e-liquids and Triton and G6 devices. With extensive U.S. and international industry experience, Ms. Kovacevic held senior legal and compliance positions at, among other, Philip Morris International and Lorillard. Prior to joining Lorillard she was a partner at Patton Boggs.  Her expertise includes global e-cigarette and tobacco regulation, compliance and all regulatory aspects of marketing/media communications, corporate affairs, criminal investigations, FCPA, trade sanctions, privacy, product development and launch. Ms. Kovacevic serves on the advisory board of the Global Tobacco and Nicotine Forum. In the past she was a United Nations staff member, served on UN’s Public-Private Partnership Commission and was also an advisor to the Council for Burley Tobacco. Ms. Kovacevic is admitted to practice in New York and before the Supreme Court of the United States. She holds a Juris Doctor degree from Columbia Law School (NY) and has completed the Harvard Business School “Corporate Leader” course. She is fluent in seven European languages.
A.Kryvosheyev 030 Alexander Kryvosheyev was appointed vice president, of corporate affairs, for Japan Tobacco International. A Ukrainian national, Kryvosheyev joined R.J. Reynolds International in 1994 in Kiev as public relations specialist and transferred to JTI’s headquarters in Geneva in 2002, holding various positions in the corporate affairs and regulatory affairs departments. Kryvosheyev holds a degree from a foreign languages institute in Kiev, where he also started his career in 1987.
mike ligon Mike Ligon is vice president of Universal Leaf Tobacco Co., responsible for worldwide management of government and corporate affairs. He focuses on regulatory issues related to the U.S. Food and Drug Administration’s Family Smoking Prevention and Tobacco Control Act and the Framework Convention on Tobacco Control as well as trade agreements under the World Trade Organization. Ligon joined Universal in 1982. His previous positions include president of Universal’s CASA Export, president of America’s Harvest and sales director for Universal Leaf North America. Ligon serves on the tobacco industry-related boards of Eliminate Child Labor in Tobacco and the TMA as well as three other nonprofit organizations in the Richmond, Virginia, USA, area.
MURPHY_2015 Marina Murphy is scientific reputation manager at British American Tobacco (BAT) and secretary of the GTNF advisory board. She joined BAT in 2008 as scientific communications manager and became the driving force behind a communications strategy designed to reflect BAT’s transparent approach to scientific communication. The strategy‘s goal is to provide clear communication and engender debate on the company’s ambitious tobacco harm-reduction research program, including the creation of lower-risk tobacco products. Prior to joining BAT, she was a science journalist.
mike ogden Mike Ogden is RAI Services’ senior director for regulatory oversight, based in North Carolina, USA. Ogden is responsible for scientific and regulatory advocacy and engagement for all Reynolds American tobacco operating companies. Previously, Ogden was in charge of various R&D programs for R.J. Reynolds Tobacco Co., including those related to environmental tobacco smoke, measuring smoke uptake in smokers through the use of biomarkers, smoking behavior research, clinical studies, regulatory compliance activities, and scientific and regulatory strategy.
michiel reerink Michiel Reerink is global regulatory strategy vice president at Japan Tobacco International (JTI). He started his career in the tobacco industry in 1996 at a tobacco trade association in the Netherlands. In 2001, he joined a major tobacco company to take responsibility for corporate affairs in the Netherlands, Benelux and Germany. In 2004, he established the company’s EU affairs office in Brussels and subsequently led its EU engagement. In 2010, Reerink joined JTI at the Geneva, Switzerland, headquarters to head the global regulatory strategy department, which leads JTI’s strategy and responses to emerging global priority issues, including plain packaging.
jim solyst Jim Solyst is vice president, federal regulatory affairs, Swedish Match North America. He directs the company’s modified-risk tobacco products process and engages the tobacco control, public health and scientific communities. During his time in Washington, Solyst worked with agencies such as the Environmental Protection Agency, the U.S. Food and Drug Administration and the Office of Management and Budget. He has also worked with the United Nations, the World Health Organization and the Organisation for Economic Cooperation and Development. Solyst is a member of the Food Drug Law Institute Tobacco Committee and the American Chemical Society Committee on Environmental Improvement.
ron tully Ron Tully is National Tobacco Co.’s (NTC) vice president of public affairs and new projects. He is responsible for FDA regulatory issues as well as federal, state and local legislative issues and industry trade relations. Tully also serves on the steering groups of the Coalition of Independent Tobacco Manufacturers of America and the Small Business Cigar Coalition. He is a board member of the National Association of Tobacco Outlets and the Pipe Tobacco Council. In addition to his regulatory responsibilities, Tully also identifies and develops new business opportunities for NTC worldwide. Previously Tully worked for Santa Fe Natural Tobacco Co. and the International Tobacco Documentation Center in London.
huub Huub Vizée is Delfortgroup’s head of regulatory affairs. Based in Austria, he is responsible for dealing with all tobacco-related regulatory issues worldwide. Vizée also is vice president of Coresta.
Prior to joining Delfortgroup, in September 2011, Vizée worked for Van Nelle, Douwe Egberts and Imperial Tobacco, where his last position was head of group regulatory development. In this role he was responsible for leading Imperial Tobacco’s regulatory engagement as an active participant on a global, regional and market level. He also represented Imperial Tobacco on the boards of CECCM, ECMA and Coresta.
Vizée has worked in the tobacco industry for 28 years, in areas such as leaf, research, engineering, quality assurance, product development and corporate affairs.
Jeffrey Walker is VP & chief medical officer, Altria Client Services. Jeff’s background is a blend of medical device, drug delivery and combination drug/device experience, often focusing on complex implantable products and technologies that require a controlled, highly targeted drug delivery from a variety of medical device platforms. As the Chief Medical Officer of Altria Client Services, Jeff leads the scientific engagement with FDA and FDA Scientific Committees for current and future product applications as well as engagement to provide FDA with the company perspective on an appropriate regulatory framework for tobacco products.
Hosted By: